Previous Article | Next Article ![]()
Infection and Immunity, May 1999, p. 2475-2481, Vol. 67, No. 5
Department of Medicine, Division of Infectious Diseases,
St. John's Cardiovascular Research Center, LAC-Harbor UCLA Medical
Center, Torrance, California 90509,1 and
School of Medicine2 and
Department of Psychiatry and Biobehavioral Sciences,
Received 8 September 1998/Returned for modification 6 January
1999/Accepted 26 February 1999
Thrombin-induced platelet microbicidal protein 1 (tPMP-1) is a
small, cationic peptide generated from rabbit platelets when they are
exposed to thrombin in vitro. It has potent microbicidal activity
against a broad spectrum of bacterial and fungal pathogens, including
Staphylococcus aureus. Previous in vitro studies involving whole staphylococcal cells and planar lipid bilayers (as artificial bacterial membrane models) suggested that membrane permeabilization by
tPMP-1 is voltage dependent (S.-P. Koo, M. R. Yeaman, and A. S. Bayer, Infect. Immun. 64:3758-3764, 1996; M. R. Yeaman,
A. S. Bayer, S. P. Koo, W. Foss, and P. M. Sullam,
J. Clin. Investig. 101:178-187, 1998). Thus, the aims of the
present study were to specifically characterize the
electrophysiological events associated with membrane permeabilization
by tPMP-1 by using artificial planar lipid bilayer membranes. We
assessed the influence of transmembrane voltage polarity and magnitude
on the initiation and modulation of tPMP-1 membrane permeabilization at
various concentrations of tPMP-1 (range, 1 to 100 ng/ml) added to the
cis side of the membranes. The incidence of membrane
permeabilization induced by tPMP-1 at all of the concentrations tested
was more frequent at Mammalian platelets are believed to
be integral components of host defense against blood-borne microbial
pathogens. This function likely occurs through platelet-released
antimicrobial peptides at sites of endovascular damage or infection
(17-22). These antimicrobial peptides have been termed
platelet microbicidal proteins or PMPs (19).
Thrombin-induced PMP-1 (tPMP-1) is the predominant peptide isolated
from thrombin-stimulated rabbit platelets in vitro (20, 22).
It is small (molecular mass, 8,036 Da, as determined by mass
spectroscopy) and has an amino acid composition indicative of a
cationic peptide with a relatively high abundance of basic residues
(Arg, Lys, and His; 23.8% of the total mass) (22). tPMP-1
exerts potent antimicrobial activities against common bloodstream pathogens, including Staphylococcus aureus, S. epidermidis, viridans group streptococci, Candida
albicans, and Cryptococcus neoformans (17-22). In vitro, tPMP-1 microbicidal activity is most
active at pH 7.2 and under conditions of low ionicity (9,
23).
Recent data from our laboratories support the hypothesis that tPMP-1
targets the bacterial cytoplasmic membrane to initiate its microbicidal
effects (8-10, 23). In addition, preliminary investigations
using planar lipid bilayer systems to simulate microbial membranes
indicated that tPMP-1 directly permeabilizes such membranes, increasing
conductance in a voltage-dependent manner (10). In prior
studies, the initiation of tPMP-1 membrane permeabilization appeared to
be voltage dependent, while persistence of a membrane effect due to
tPMP-1 was not voltage driven. Using genetically related parent-mutant
S. aureus strain pairs which differ in transmembrane
electrical potential ( Platelet microbicidal proteins.
Fresh rabbit platelets were
isolated and stimulated with bovine thrombin in glutamine-free Eagle's
minimal essential medium (pH 7.4; Irvine Scientific), yielding
tPMP-1-rich supernatant, as described elsewhere (19).
Previous sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(PAGE) and high-pressure liquid chromatography (HPLC) analyses have
indicated that tPMP-1 is the predominant cationic staphylocidal peptide
present therein (19, 22). tPMP-1 was then homogeneously
purified from the respective platelet supernatants by gel filtration
and analytical reversed-phase HPLC (22). The purity of the
peptide was confirmed by acid-urea PAGE, sodium dodecyl sulfate-PAGE,
and reversed-phase HPLC (22). Retention of microbicidal
activity by purified tPMP-1 was confirmed by 100% killing of
103 CFU of Bacillus subtilis ATCC 6633, an
indicator organism highly susceptible to the peptide, per ml at 37°C
within 30 min as described elsewhere (19, 22). Pilot studies
indicated that tPMP-1 solubilization in 10% (vol/vol) dimethyl
sulfoxide for 5 min at room temperature (before dilution and use) was
optimal for measurement of activity on artificial planar lipid bilayers
(data not shown).
Planar lipid membrane apparatus.
Planar lipid bilayer
membranes were formed across the end of a Teflon tube (diameter, 0.5 mm) which was tightly fitted into a chamber containing a small central
conduit (volume capacity, ~100 µl) as described elsewhere
(14). The tube was coated with a lipid solution consisting
of 1.5% (wt/vol)
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) (7:3 [wt/wt]; Avanti Polar Lipids Inc., Birmingham, Ala.) in
n-heptane and allowed to dry. The tube was then positioned
such that the membrane, when formed, would lie in the central flow of
the conduit filled with an ionic buffer. Our previous microbicidal
assays and flow cytometry studies have shown that tPMP-1 is functional at neutral pH. Therefore, a buffer consisting of 0.1 M KCl containing 10 mM Tris-HCl (pH 7.4) was used to bathe the membrane (22, 23). The anionic planar lipid bilayers were formed by aeration of
the POPC-POPG lipid mixture across the tubing. A voltage potential was
generated across the membrane by using a pair of Ag-AgCl electrodes, one of which was linked to a battery voltage source. The complementary electrode was connected to a measuring circuit consisting of a current
amplifier and a chart recorder. Voltage polarity was defined by the
addition of HPLC-purified tPMP-1 to the designated cis side
of membranes. A trans-negative or trans-positive
potential (indicated by a minus or plus sign, respectively) was
generated by applying a negative or positive potential, respectively,
to the compartment opposite the peptide-containing cis side
(i.e., the trans compartment). The chamber was constructed
such that the test peptide (diluted in buffer) could be added within
seconds to rapidly displace peptide-free buffer in the cis compartment.
Voltage-dependent membrane permeabilization studies.
All
experiments were performed at room temperature. All studies represent
at least two independent experiments performed under the same
conditions. Membrane permeabilization was recorded over time as an
increase in transmembrane current and expressed in nanoamperes.
Membrane conductance (g; expressed in nanosiemens) was
calculated from Ohm's law as follows: g = I/V, where
I is current and V is voltage. Only membranes
with a baseline conductance of less than 10 pS were used in these
studies. Further, the stability of each membrane was tested by holding
membranes at (i) Initiation of planar membrane permeabilization by
tPMP-1.
The initiation of tPMP-1 membrane activity was studied by
varying the polarity of transmembrane voltages between (ii) Modulation of ongoing membrane permeabilization.
Modulation of ongoing membrane permeabilization by voltage was studied
for tPMP-1 by monitoring membrane current while alternating between
trans-positive and trans-negative voltages of
increasing magnitude (range, 30 to 100 mV). Mean membrane current was
then calculated for an interval of 5 min at selected voltages in each experiment, beginning from the time when membrane potential was initiated. Spontaneous reversibility of tPMP-1 membrane
permeabilization was investigated by gently and continuously flushing
the cis side of the planar lipid bilayer chamber with excess
buffer during permeabilization events (i.e., while membrane current was
increasing or decreasing, respectively). During such procedures,
tPMP-1-containing buffer on the cis side of membranes was
replaced with peptide-free buffer.
Statistical analysis.
Differences in the means (± the
standard deviation) of multiple groups were compared by using
Kruskal-Wallis analysis of variance, with Tukey post hoc analysis for
multiple comparisons of nonparametric data. P tPMP-1-induced membrane permeabilization.
Unmodified lipid
bilayer membranes exhibited low membrane conductance which was
indistinguishable from the background (~3 pS). Dimethyl sulfoxide
(final concentration, 0.01 to 0.2%, vol/vol) or KCl buffer alone did
not alter membrane permeabilization (conductance) when added to the
cis side of planar lipid bilayer membranes over a 20- to
40-min observation period (data not shown). However, tPMP-1 at
concentrations as low as 1 ng/ml induced an increase in membrane
permeability of 103- to 105-fold within minutes
of peptide addition (Fig. 1A).
Conductance induced by tPMP-1 fluctuated on a millisecond time scale,
with no apparent single-channel characteristics, consistent with
previous pilot studies (Fig. 1B) (10). Once membrane
permeabilization was initiated, one of two subsequent effects on
membrane conductance was noted as the transmembrane voltage was held
constant. First, membrane conductance increased to one or more apparent
steady-state levels, with moderate fluctuations persisting throughout
an observation period of more than 60 min (Fig. 1B). Alternatively,
membrane conductance increased rapidly, within a few seconds, leading
to rupture of the membrane. Both trans-negative and
trans-positive voltages of
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Membrane Permeabilization by Thrombin-Induced
Platelet Microbicidal Protein 1 Is Modulated by Transmembrane Voltage
Polarity and Magnitude
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
90 mV than at +90 mV. It is noteworthy that
membrane permeabilization due to 1-ng/ml tPMP-1 was successfully
initiated at
90 mV but not at +90 mV. Further, the mean onset times
of induction of tPMP-1 activity were comparable under the various
conditions. Modulation of ongoing membrane permeabilization was
dependent on voltage and tPMP-1 concentration. Membrane
permeabilization at a low tPMP-1 concentration (1 ng/ml) was directly
correlated with trans-negative voltages, while a higher
tPMP-1 concentration (100 ng/ml) induced conductance which was more
dependent on trans-positive voltages. Collectively, these
data indicate that the mechanism of tPMP-1 microbicidal activity at the
bacterial cytoplasmic membrane may involve distinct induction and
propagation stages of membrane permeabilization which, in turn, are
modulated by transmembrane potential, as well as peptide concentration.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

), we previously demonstrated that a
lowered 
in the mutants was directly related to a decrease in
membrane permeabilization and a decrease in tPMP-1 susceptibility
(8, 23). Collectively, these observations led us to
hypothesize that 
influences tPMP-1 membrane activity at two
possible levels, i.e., (i) induction of membrane permeabilization and
(ii) ongoing modulation of membrane perturbation, leading to eventual
membrane disruption. The present study aimed to further characterize
these electrophysiologic events in vitro by using artificial planar
lipid bilayers as model bacterial cytoplasmic membranes.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
90 mV for 20 to 30 min in buffer alone. The influence of
differing transmembrane voltages on tPMP-1 membrane activity was
studied by evaluating two events, i.e., initiation of planar membrane
permeabilization by tPMP-1 and modulation of ongoing membrane permeabilization.
90 and +90 mV
and tPMP-1 concentrations from 1 to 100 ng/ml. Rapidity of tPMP-1
membrane permeabilization was determined by measuring the time to onset
of activity from the point of addition of tPMP-1 to planar lipid
bilayers to the initial increase in membrane current. Times to onset
inversely relate to the ability of tPMP-1 to initiate permeabilization
of membranes under selected electrophysiologic conditions. Previous
studies of other cationic peptides (e.g., defensins), as well as
tPMP-1, suggested that they permeabilize negatively charged lipid
bilayers (5, 10). Furthermore, previous experiments using
similar artificial planar lipid bilayer systems with tPMP-1 or other
peptides indicated that membrane activity, if present, generally occurs
within 10 min of peptide addition (data not shown). Thus, membranes in
these experiments were observed for up to 10 min after the addition of
tPMP-1. In selected studies, the mean magnitude of membrane conductance
within the first 20 s of permeabilization was determined at the
various trans-positive and trans-negative
voltages and tPMP-1 concentrations.
-amyloid peptide, A
(25-35), is a
voltage-dependent ionic-channel former that exhibits an increase in
membrane conductance (open state) at trans-negative voltages
and a decrease (closed state) at trans-positive voltages (13). Thus, this peptide (10 µg/ml) was used as a positive
control for voltage magnitude and polarity in the present study.
0.05
was considered significant.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
90 and +90 mV, respectively,
induced tPMP-1 membrane permeabilization, although their frequencies
varied (Table 1; also see below).

View larger version (16K):
[in a new window]
FIG. 1.
Membrane conductance induced by tPMP-1 in planar lipid
bilayer membranes. Membrane conductance is shown as a function of time
with reference to the scales indicated. A planar lipid bilayer membrane
was bathed in a 0.1 M KCl salt solution containing 10 mM Tris-HCl (pH
7.4) and maintained at a membrane potential of
90 mV throughout the
experiment. For panel A, the resting membrane was held at rest for 35 min before the addition of tPMP-1 (arrow). An increase in membrane
permeabilization was noted within 60 s of peptide addition. In
panel B, the ongoing membrane conductance induced in panel A is
displayed on a different scale.
TABLE 1.
Frequency and time to onset of tPMP-1 activity
Voltage-dependent initiation of tPMP-1 activity.
The mean
times to onset of membrane permeabilization (minutes) for 1-, 10-, or
100-ng/ml tPMP-1 at
90 or +90 mV are shown in Table 1. When membrane
permeabilization was not observed within 10 min of tPMP-1 addition,
A
(25-35) was added to the same membrane to confirm the sensitivity
of the membrane to permeabilization. A
(25-35) (10 µg/ml) was
~100% effective at inducing membrane permeabilization within 1 min
of peptide addition to membranes (data not shown). At 1-ng/ml tPMP-1,
membrane permeabilization was induced at
90 mV but not at +90 mV. At
the 1-, 10-, and 100-ng/ml tPMP-1 concentrations tested, membrane
permeabilization was consistently induced at higher incidences (40, 57, and 83%, respectively) at a trans-negative voltage (
90
mV) than at the equivalent trans-positive voltage (+90 mV;
0, 17, and 40%, respectively; Table 1). The times of onset of induced
membrane permeabilization observed at
90 versus +90 mV (range, 0.8 to
3.8 min) were not statistically significantly different at the various
tPMP-1 concentrations used. In selected experiments, the mean initial
magnitude of membrane conductance induced by tPMP-1 within the first
20 s of activity was determined at both
90 and +90 mV for the
various tPMP-1 concentrations. The data reveal no significant influence
of either voltage polarity or tPMP-1 concentration on the magnitude of
membrane conductance (data not shown).
Voltage-dependent modulation of tPMP-1 activity.
Once tPMP-1
membrane permeabilization was initiated, the modulation of this
activity was influenced by both voltage magnitude and polarity, as well
as by tPMP-1 concentration. For example, Fig. 2A to
C shows strong but differing patterns of
influence of voltage on tPMP-1 permeabilization at 1-, 40-, and
100-ng/ml tPMP-1, respectively. At 1-ng/ml tPMP-1, membrane
permeabilization was directly related to trans-negative
voltages, while membrane permeabilization was much lower and nearly
constant at corresponding trans-positive voltages (Fig. 2A).
As the voltage was increased from
60 to
100 mV, membrane
permeabilization and current fluctuations became greater, finally
rupturing the membrane at
100 mV (Fig. 2A). In contrast, membrane
permeabilization induced at 40-ng/ml tPMP-1 increased at
trans-positive voltages, while trans-negative voltages had the opposite effect (Fig. 2B). An increase in conductance was noted at +40 mV or above, while a decrease in membrane conductance occurred at
40 mV or lower (Fig. 2B). At 100-ng/ml tPMP-1, membrane permeabilization showed strong dependence on voltage polarity, with
membrane conductance at +90 mV being ~10-fold greater than at
90 mV
(Fig. 2C). The membrane was eventually ruptured at +90 mV (Fig. 2C).
Attempts to reverse tPMP-1 membrane permeabilization by flushing the
planar lipid bilayer chamber with excess buffer were routinely
unsuccessful during either opening or closing events of membrane
permeabilization.
|
Transmembrane current versus voltage.
Voltage-dependent
membrane permeabilization induced by tPMP-1 or A
(25-35) was
further analyzed by calculating the mean membrane current from an
interval of 5 min after each voltage change, as described in Materials
and Methods (Fig. 3A to E). At 1-ng/ml tPMP-1, substantial voltage dependence of membrane permeabilization was
observed, particularly at trans-negative voltages below
90 mV (Fig. 3A). For example, the absolute membrane current induced at
100 mV was 2.5 nA, compared to 0.5 nA at +100 mV. At 10-ng/ml tPMP-1,
membrane current was equally influenced by both
trans-negative and trans-positive voltages (Fig.
3B). It is interesting that membrane permeabilization at 40- or
200-ng/ml tPMP-1 was modulated in a manner opposite to that observed at
1-ng/ml tPMP-1 (Fig. 3C and D). A strong, nonlinear increase in
membrane current was observed at trans-positive voltages
above +40 and +60 mV for 40- and 200-ng/ml tPMP-1, respectively, while
trans-negative voltages only induced linear (ohmic)
increases at these tPMP-1 concentrations (Fig. 3C and D). Although
membrane current at trans-negative voltages was at least
2.5-fold lower than at trans-positive voltages in both
cases, the increase in membrane permeabilization of the former from the
baseline was still substantial (~103-fold). Comparison of
the membrane current levels induced at trans-negative voltages for 1-ng/ml tPMP-1 (Fig. 3A) versus 200-ng/ml tPMP-1 (Fig. 3D)
indicates that they are comparable. It is noteworthy that membrane
permeabilization for 40- or 200-ng/ml tPMP-1 was induced at
90 or
150 mV, respectively. Despite differences in induction voltage and
peptide concentration, the overall effects of voltage on membrane
permeabilization appear to be comparable (Fig. 3C and D). As expected,
A
(25-35) exhibited strong voltage-dependent opening at
trans-negative voltages and closing at
trans-positive voltages, consistent with previous
observations (Fig. 3E) (13).
|
| |
DISCUSSION |
|---|
|
|
|---|
Our current hypothesis contends that tPMP-1 initially targets the
bacterial cytoplasmic membrane, leading to membrane permeabilization as
a principal mechanism of bactericidal action. This belief is supported
by several previous observations, including (i) rapid permeabilization
of cytoplasmic membranes of whole staphylococcal cells and protoplasts
within seconds of tPMP-1 exposure (10, 23) and (ii)
tPMP-1-induced increases in conductance across artificial planar lipid
bilayers, indicating direct permeabilization of the membrane by tPMP-1
(10). In addition, previous evidence indicates that
staphylocidal activity and membrane permeabilization due to tPMP-1 are
voltage dependent, with activity being facilitated by a 
of
100
mV or a more negative voltage (8, 23). For example, two
genetically distinct tPMP-1-resistant mutants (S. aureus
JB-1 and 19R) exhibit substantially lower 
values (
98 and
102
mV, respectively) than their genetically related tPMP-1-susceptible parental strains (S. aureus 6850 and 19S, respectively) with
intact 
values (
150 and
132 mV, respectively) (2,
8). Moreover, tPMP-1-induced membrane permeabilization of a
parent-mutant strain pair (whole cells or protoplasts) was directly
related to 
(10, 23). Furthermore, reconstitution of

in the mutant strain is associated with enhanced killing and
permeabilization by tPMP-1 to near-parental levels (8, 23).
These findings are similar to the protection that membrane
depolarization affords Escherichia coli against the
voltage-dependent channel-forming colicins (12, 16). Lastly,
preliminary studies using planar lipid bilayers and whole
staphylococcal cells indicated that the induction of tPMP-1 membrane
permeabilization is facilitated by a transmembrane potential of at
least
90 mV (10, 23). Despite these important findings,
the specific biophysical relationships among 
, tPMP-1 concentration, and tPMP-1-induced membrane permeabilization have not
been fully delineated. Thus, the present study aimed to further test
this hypothesis and to characterize the electrophysiologic consequences
of tPMP-1 interactions with membranes.
The planar lipid bilayer membrane technique used in our current investigation has been utilized by numerous investigators to study membrane permeabilization by antimicrobial peptides (3, 4, 7, 11, 15). The characteristics of peptide-membrane interactions, which can be reliably determined by using this method, include the following parameters: (i) onset time to membrane permeabilization, (ii) extent of membrane permeabilization, (iii) voltage threshold for the induction of membrane permeabilization, and (iv) influence of voltage polarity and magnitude on ongoing membrane permeabilization. The lipid composition of planar lipid bilayer membranes used in the present study (i.e., a POPC/POPG ratio of 7:3 [wt/wt]) differs from that of bacterial membranes in that the latter contain cardiolipin and neutral lipids consisting mainly of phosphatidylethanolamine instead of phosphatidylcholine. The artificial membranes have a net negative surface charge due to the 30% content of the negatively charged lipid POPG with no cationic lipid. Thus, despite differences in lipid composition, the surface charge of the artificial membranes reflects the net anionic surface charge of bacterial membranes. This was important for the purpose of the current study, since it has been shown that cationic peptides which are similar to tPMP-1 (e.g., defensins) likely target anionic membranes (5, 7).
Membrane permeabilization was induced by tPMP-1 at concentrations as low as 1 ng/ml. Our data show that membrane conductance with variable fluctuations was induced by tPMP-1 with no clear indication of single-channel activity. The high frequency of membrane rupture, together with the high variability of membrane conductance induced by tPMP-1, indicates that membrane permeabilization most likely occurs by a generalized breakdown of the membrane structure. However, several aspects of our data might also suggest that pore formation participates in tPMP-1-induced activity: (i) it is known that stable, long-lived single-channel activities induced by channel-forming peptides such as defensins are difficult to detect due to the highly heterogeneous population of channel currents, even under stringent conditions (7); (ii) membrane conductance induced by tPMP-1, although showing a high degree of fluctuation, did reach one or more apparent steady-state levels under a given condition; (iii) rectification of conductance was also observed under most circumstances, whereby conductance induced by corresponding positive and negative voltages appear asymmetrical; and (iv) tPMP-1 activity is voltage dependent, similar to those of other pore-forming cationic peptides, such as defensins (7). The present data are not sufficient to precisely distinguish between the two possible mechanisms of tPMP-1 action, namely, generalized breakdown of the membrane [so-called "carpet effect"] versus discrete pore formation. Thus, the possibility of permeabilization of target membranes by the formation of porelike structures by tPMP-1 cannot be excluded.
Collectively, the present data demonstrate several important points
regarding the mechanism of tPMP-1-induced membrane permeabilization. First, permeabilization of artificial membranes due to tPMP-1 was
voltage dependent in terms of induction and propagation events. This
observation supports our previous finding that bacterial 
(featuring a trans-negative voltage) appears to drive tPMP-1 permeabilization of the cytoplasmic membrane, a principal target of
tPMP-1 activity (8, 10, 23). In the current study involving the induction of permeabilization of artificial membranes, a two- to
fourfold higher incidence of permeabilization was observed at
trans-negative than at trans-positive voltages.
Further, current-versus-voltage plots of ongoing membrane
permeabilization induced by tPMP-1 indicate a 103-fold
increase in membrane permeabilization at a trans-negative voltage of
100 mV. Second, there appears to be an optimum threshold potential of approximately
100 mV for the interaction of tPMP-1 with
artificial membranes, beyond which membrane activity progresses from
permeabilization to disruption of the membrane. These data are
supportive of our prior observation that a bacterial 
above
100
mV (e.g.,
150 mV) is required for maximal tPMP-1 activity (8,
10, 23). Finally, failure to diminish tPMP-1 membrane permeabilization by flushing the cis side of the membranes
with excess tPMP-1-free buffer suggests that association of tPMP-1 with
membranes is not spontaneously reversible. Taken together with previous
data (10, 23), our findings indicate that the mechanism of
tPMP-1 activity involves 
-dependent permeabilization of the
bacterial cytoplasmic membrane; this may lead to global membrane
destabilization and ultimate rupture.
It should be emphasized that, in addition to the electrophysiologic state of the target cytoplasmic membrane, several other determinants have been identified which appear to influence tPMP-1 microbicidal activity. Previous studies indicate that logarithmic-phase staphylococcal cells and protoplasts are more resistant to killing and membrane disruption by tPMP-1, respectively, than are stationary-phase cells of the same strains (9, 10). Also, tPMP-1-resistant staphylococcal strains have membrane bioenergetics that differ (e.g., an increased basal rate of O2 consumption and ATP generation) from those of their genetically related tPMP-1-susceptible counterparts (2). Moreover, the cytoplasmic membrane composition of tPMP-1-resistant staphylococcal strains shows an increase in polyunsaturated fatty acids, with a resultant increase in membrane fluidity, compared to that of their tPMP-1-susceptible counterparts (1). Taken together, these data suggest that the microbial growth phase, the overall state of cellular bioenergetics, and the lipid composition of the cytoplasmic membrane profoundly influence tPMP-1 staphylocidal activity in vitro. The precise interrelationships among these parameters with respect to tPMP-1 susceptibility or resistance remain to be elucidated.
tPMP-1 exhibited an unusual concentration-dependent effect on voltage-dependent membrane permeabilization. At a low tPMP-1 concentration (1 ng/ml), membrane permeabilization was greater at trans-negative voltages. At higher concentrations (40 to 200 ng/ml), membrane permeabilization was greater at trans-positive voltages, while a moderate concentration (10 ng/ml) exhibited an intermediate pattern. Similar concentration-dependent electrophysiologic activities have been shown for the channel-forming bacterial peptide monazomycin, which undergoes altered voltage dependence as its concentration increases (6). Thus, the present phenomena may represent a novel aspect of the mechanism of action of tPMP-1 among mammalian endogenous antimicrobial peptides.
Concentrations of tPMP-1 necessary to induce membrane permeabilization in the present study (i.e., 1 to 100 ng/ml, corresponding to 0.125 to 12.5 nM, respectively) are consistent with those which exert microbicidal activities against S. aureus and B. subtilis in vitro (22). The functional concentration of tPMP-1 released from platelets at putative sites of action (i.e., sites of endothelial damage and microbial colonization) is not specifically known (19, 22). However, the relative abundance of tPMP-1 from thrombin-stimulated rabbit platelets in vitro is ~15 µg/109 platelets, 100-fold higher than the highest concentration used in the current study (22). Assuming that only a fraction of the platelet population which is deposited at the site of infection is stimulated to release tPMP-1, it is highly likely that tPMP-1 concentrations encompassing those used in the current study exist in settings of infection in vivo. Thus, the present in vitro findings may also have implications for the mechanism of antimicrobial host defense of platelets in vivo.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by research grants from the National Institutes of Health (AI39108 to A.S.B. and M.R.Y., AI39001 to M.R.Y., and MH01174 to B.L.K.), the University of California AIDS Research Program (to B.L.K.), and the UCLA AIDS Institute (to B.L.K.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medicine, Division of Infectious Diseases, St. John's Cardiovascular Research Center, RB-2, Los Angeles County-Harbor UCLA Medical Center, 1000 West Carson St., Torrance, CA 90509. Phone: (310) 222-6423. Fax: (310) 782-2016. E-mail: KOO{at}AFP76.HUMC.EDU.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bayer, A. S., M. R. Yeaman, S.-P. Koo, and R. Prasad. 1997. Resistance to staphylocidal effects of thrombin-induced microbicidal protein is associated with alterations in membrane fluidity and lipid content, abstr. A-107, p. 19. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C. |
| 2. | Bayer, A. S., M. R. Yeaman, H.-G. Sahl, D. Brar, and R. A. Proctor. 1997. Relationship of phenotypic resistance to thrombin-induced platelet microbicidal protein (tPMP) and cytoplasmic membrane bioenergetics in Staphylococcus aureus (SA), abstr. A-106, p. 19. In Abstracts of the 97th General Meeting of the American Society for Microbiology 1997. American Society for Microbiology, Washington, D.C. |
| 3. |
Christensen, B.,
J. Fink,
R. B. Merrifield, and D. Mauzerall.
1988.
Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes.
Proc. Natl. Acad. Sci. USA
85:5072-5076 |
| 4. |
Falla, T. J.,
D. N. Karunaratne, and R. E. W. Hancock.
1996.
Mode of action of the antimicrobial peptide indolicidin.
J. Biol. Chem.
271:19298-19303 |
| 5. | Fujii, G., M. E. Selsted, and D. Eisenberg. 1993. Defensins promote fusion and lysis of negatively-charged membranes. Protein Sci. 2:1301-1312[Abstract]. |
| 6. |
Heyer, R. J.,
R. U. Muller, and A. Finkelstein.
1976.
Inactivation of monazomycin-induced voltage-dependent conductance in thin lipid membranes. II. Inactivation produced by monazomycin transport through the membrane.
J. Gen. Physiol.
67:731-748 |
| 7. |
Kagan, B. L.,
M. E. Selsted,
T. Ganz, and R. I. Lehrer.
1990.
Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes.
Proc. Natl. Acad. Sci. USA
87:210-214 |
| 8. | Koo, S.-P., A. S. Bayer, H.-G. Sahl, R. A. Proctor, and M. R. Yeaman. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect. Immun. 64:1070-1074[Abstract]. |
| 9. | Koo, S.-P., M. R. Yeaman, and A. S. Bayer. 1996. Staphylocidal action of thrombin-induced platelet microbicidal protein is influenced by microenvironment and target cell growth phase. Infect. Immun. 64:3758-3764[Abstract]. |
| 10. | Koo, S.-P., M. R. Yeaman, C. C. Nast, and A. S. Bayer. 1997. The cytoplasmic membrane is a primary target for the staphylocidal action of thrombin-induced platelet microbicidal protein. Infect. Immun. 65:4795-4800[Abstract]. |
| 11. |
Kordel, M.,
R. Benz, and H.-G. Sahl.
1988.
Mode of action of the staphylococcinlike peptide Pep5: voltage-dependent depolarization of bacterial and artificial membranes.
J. Bacteriol.
170:84-88 |
| 12. | Luria, S. E. 1975. Colicins and the energetics of cell membranes. Sci. Am. 233:30-37[Medline]. |
| 13. | Mirzabekov, T. A., M.-C. Lin, W.-L. Yuan, P. J. Marshall, M. Carman, K. Tomaselli, I. Lieberburg, and B. L. Kagan. 1994. Channel formation in planar lipid bilayers by a neurotoxic fragment of the beta-amyloid peptide. Biochem. Biophys. Res. Commun. 202:1142-1148[Medline]. |
| 14. | Mirzabekov, T. A., A. V. Silberstein, and B. L. Kagan. 1999. Use of planar lipid bilayer membranes for rapid screening of membrane active compounds. Methods Enzymol. 294:661-674[Medline]. |
| 15. | Sahl, H.-G., M. Kordel, and R. Benz. 1987. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch. Microbiol. 149:120-124[Medline]. |
| 16. | Schein, S. J., B. L. Kagan, and A. Finkelstein. 1978. Colicin K acts by forming voltage-dependent channels in phospholipid bilayer membranes. Nature 276:159-163[Medline]. |
| 17. | Sullam, P. M., U. Frank, M. G. Tauber, M. R. Yeaman, A. S. Bayer, and H. F. Chambers. 1993. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J. Infect. Dis. 168:910-914[Medline]. |
| 18. |
Wu, T.,
M. R. Yeaman, and A. S. Bayer.
1994.
In vitro resistance to platelet microbicidal protein correlates with endocarditis source among staphylococcal isolates.
Antimicrob. Agents Chemother.
38:729-732 |
| 19. |
Yeaman, M. R.,
S. M. Puentes,
D. C. Norman, and A. S. Bayer.
1992.
Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein.
Infect. Immun.
60:1202-1209 |
| 20. |
Yeaman, M. R.,
A. S. Ibrahim,
J. E. Edwards, Jr.,
A. S. Bayer, and M. A. Ghannoum.
1992.
Thrombin-induced platelet microbicidal protein is fungicidal in vitro.
Antimicrob. Agents Chemother.
37:546-553 |
| 21. | Yeaman, M. R., S. S. Soldan, M. A. Ghannoum, J. E. Edwards, Jr., S. G. Filler, and A. S. Bayer. 1996. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect. Immun. 64:1379-1384[Abstract]. |
| 22. | Yeaman, M. R., Y.-Q. Tang, A. J. Shen, A. S. Bayer, and M. E. Selsted. 1997. Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect. Immun. 65:1023-1031[Abstract]. |
| 23. | Yeaman, M. R., A. S. Bayer, S.-P. Koo, W. Foss, and P. M. Sullam. 1998. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J. Clin. Investig. 101:178-187[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|